Recognizing a need to update the 2021 criteria for monitoring disease progression in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a group of international experts shared new proposed criteria, including recommendations for…
Recognizing a need to update the 2021 criteria for monitoring disease progression in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a group of international experts shared new proposed criteria, including recommendations for…